Feasibility of commercial interferon-γ-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage

Clinical Microbiology and Infection

Volumn 13, Issue 8, 2007, Pages 836-838

  Tuuminen, Tamara ^a   Sorva, S ^b   Liippo, K ^c   Vasankari, T ^c   Soini, H ^d   Eriksen Neuman B ^e   Miettinen, A ^a   Seppala I J ^d  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Diagnosis; ELISPOT; Mantoux test; Myco bacterium tuberculosis; QuantiFERON test; Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ADULT; ARTICLE; AUTOPSY; CADAVER; CELL ISOLATION; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; CULTURE MEDIUM; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSPOT ASSAY; EX VIVO STUDY; FALSE POSITIVE RESULT; FEASIBILITY STUDY; FETAL CALF SERUM; FINLAND; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MEDICAL STUDENT; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TUBERCULIN TEST;

MYCOBACTERIUM TUBERCULOSIS;

EID: 34447256574     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01750.x     Document Type: Article

References (9)

1. Pai M, Riley LW, Colford JM. Interferon-γ assays in the immunodiagnosis of tuberculosis: A systematic review. Lancet Infect Dis 2004; 4: 761-776.
2. Rothel J, Andersen P. Diagnosis of latent Mycobacterium tuberculosis infection: Is the demise of the Mantoux test imminent? Expert Rev Anti Infect Ther 2005; 3: 1-13.
3. Dheda K, Udwadia Z, Hugget JF et.al. Utility of the antigen-specific interferon (gamma) assay for the management of tuberculosis. Curr Opin Pulm Med 2005; 11: 195-202.
4. Ferrara G, Losi M, D'Amico R et.al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: A prospective study. Lancet 2006; 367: 1328-1334.
5. Richeldi L. Rapid identification of Mycobacterium tuberculosis infection. Clin Microbiol Infect 2006; 12 (suppl 9): 34-36.
6. Lalvani A, Nagvenkar P, Udwalia Z et.al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001; 183: 469-477.
7. Liebenchuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell based assay: A prospective cohort study. Lancet 2004; 364: 2196-2203.
8. + cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J Immunol Methods 2003; 278: 79-93.
9. Leyten E, Mulder B, Prins C et.al. Use of enzyme-linked immunospot assay with Mycobacterium tuberculosis specific peptides for diagnosis of recent infection with M. tuberculosis after accidental laboratory exposure. J Clin Microbiol 2006; 44: 1197-1201.